What’s New in Medications for Weight Management for People with Diabetes

The approval of semaglutide to treat obesity is causing excitement in the healthcare community working with patients with diabetes.

Read in Browser Diabetes Discoveries & Practice Blog Latest Post    |    January 26, 2022 What's New in Medications for Weight Management for People with Diabetes Weight loss can prevent, delay, or reverse type 2 diabetes, but it can be hard to maintain. That's why the approval of semaglutide to treat obesity is causing such excitement. Dr. Susan Z. Yanovski describes semaglutide and other new medications that could make weight loss more feasible for more people with type 2 diabetes—if cost barriers can be overcome. About the Expert Susan Z. Yanovski MD Dr. Yanovski coordinates obesity-related research activities across the NIH. She is a scientific advisor to the Look AHEAD (Action for Health in Diabetes) clinical study. In addition, she conducts intramural clinical research on obesity in the section on Growth and Obesity at the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

To unsubscribe, update your password, or change your email address visit our Subscriber Preference Page. For any questions or problems with this subscription service, please visit the Subscriber Help Center.

---

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · 1 Information Way, Bethesda, MD 20892 · 1-800-860-8747